Cargando…

NK cell dysfunction in patients with COVID-19

Detalles Bibliográficos
Autor principal:	Bi, Jiacheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755515/ https://www.ncbi.nlm.nih.gov/pubmed/35022604 http://dx.doi.org/10.1038/s41423-021-00825-2

Ejemplares similares

NK cell dysfunction in severe COVID-19: TGF-β-induced downregulation of integrin beta-2 restricts NK cell cytotoxicity
por: Barros-Martins, Joana, et al.
Publicado: (2022)

Human NK cells, their receptors and function [Image: see text]
por: Quatrini, Linda, et al.
Publicado: (2021)

Potential mechanisms by which impaired ketogenesis links metabolism to T‐cell dysfunction in patients with severe COVID‐19
por: Wang, Bin, et al.
Publicado: (2022)

NK Cell Dysfunction and Checkpoint Immunotherapy
por: Bi, Jiacheng, et al.
Publicado: (2019)

Transcriptomic perspectives of memory-like NK cells and aging
por: Wang, Dandan, et al.
Publicado: (2022)

Mitochondrial apoptosis: facilitator of NK cell-mediated immunotherapy
por: Ullrich, Evelyn, et al.
Publicado: (2022)

Rough operators: sphingomyelinase inhibitors spike NK cells to kill cancer
por: Carlsten, Mattias, et al.
Publicado: (2023)

Genetic tracing of HCoV-19 for the re-emerging outbreak of COVID-19 in Beijing, China
por: Yang, Jing, et al.
Publicado: (2020)

The putative mechanism of lymphopenia in COVID-19 patients
por: Wang, Xinling, et al.
Publicado: (2022)

Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody
por: Li, Fang, et al.
Publicado: (2020)

COVID-19 and Tuberculosis
por: Yang, Heng, et al.
Publicado: (2020)

Combating COVID-19 with Chloroquine
por: Hong, Wanjin
Publicado: (2020)

NK Cell Exhaustion
por: Bi, Jiacheng, et al.
Publicado: (2017)

The impact of aging and COVID-19 on our immune system: a high-resolution map from single cell analysis
por: Yang, Jing, et al.
Publicado: (2020)

AFM13: a first-in-class tetravalent bispecific anti-CD30/CD16A antibody for NK cell-mediated immunotherapy
por: Wu, Jingjing, et al.
Publicado: (2015)

Pandemic number five – Latest insights into the COVID-19 crisis
por: Häfner, Sophia Julia
Publicado: (2020)

Potential treatment of COVID-19 by inhibitors of human dihydroorotate dehydrogenase
por: Xu, Yechun, et al.
Publicado: (2020)

The Application of Corticosteroids in COVID-19: A Two-edged Sword
por: Li, Na, et al.
Publicado: (2020)

What we have learned from COVID-19 pandemic?
por: Chen, Hsiu-Hsi, et al.
Publicado: (2021)

Prevention and treatment of COVID‐19 disease by controlled modulation of innate immunity
por: Schijns, Virgil, et al.
Publicado: (2020)

Real Nano “Light Vaccine” Will Benefit to COVID-19 Pandemic Control
por: Yang, Jianshe
Publicado: (2021)

A next‐generation vaccine for broader and long‐lasting COVID‐19 protection
por: Xi, Jinxiang, et al.
Publicado: (2022)

Neutrophil activation and neutrophil extracellular traps (NETs) in COVID‐19 ARDS and immunothrombosis
por: Cesta, Maria Candida, et al.
Publicado: (2022)

Molecular Regulation of NK Cell Maturation
por: Bi, Jiacheng, et al.
Publicado: (2020)

Mapping the T cell response to COVID-19
por: Li, Junwei, et al.
Publicado: (2020)

Recent highlights on myocarditis, cardiovascular complications of COVID-19, and cardiomyopathies from the International Journal of Cardiology: Heart & Vasculature
por: Conti, Nicolina, et al.
Publicado: (2022)

Myocardial injury in patients with COVID-19
por: Lim, Gregory B.
Publicado: (2020)

Expression Regulation and Function of T-Bet in NK Cells
por: Huang, Chen, et al.
Publicado: (2021)

Preventing cardiac damage in patients with COVID-19
por: Robson, Andrew
Publicado: (2021)

Asynchronous actions of immune responses in COVID-19 patients
por: Shi, Yufang, et al.
Publicado: (2020)

Niemann-Pick disease and platelet dysfunction
Publicado: (2012)

Door to the cell for COVID-19 opened, leading way to therapies
por: Huang, Zhiwei, et al.
Publicado: (2020)

Single-cell transcriptomics reveals neuroinflammation in severe COVID-19
por: Lemprière, Sarah
Publicado: (2021)

Mutant huntingtin in the hypothalamus causes metabolic dysfunction
Publicado: (2011)

New data emerging on outcomes for patients with COVID-19 and rheumatic diseases
por: Onuora, Sarah
Publicado: (2020)

Don't sugar coat the COVID (only the vasculature)
por: Häfner, Sophia Julia
Publicado: (2020)

Cell perturbation in choroid plexus and cortex aiding COVID-19 neurological symptoms
por: Mao, Xiao-Yuan, et al.
Publicado: (2021)

Type I IFN deficiency: an immunological characteristic of severe COVID-19 patients
por: Wang, Zhenling, et al.
Publicado: (2020)

Ending the COVID-19 pandemic
por: Attwaters, Michael
Publicado: (2022)

Early treatment for COVID-19
por: Du Toit, Andrea
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v1dgmdq3t1lbccjbjr2kltrm1d